Download
https://www.ndtvprofit.com/business/shire-says-it-will-recommend-64-billion-revised-bid-from-takeda?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Takeda Pharma slumped the most in almost 5 years after increasing bid for Shire to about $64 billion.
Share